Results 141 to 150 of about 4,861 (176)

Increased Musashi-2 and Decreased NUMB Protein Levels Observed in Human Colorectal Cancer are reverted to Normal Levels by ATRA-Induced Cell Differentiation. [PDF]

Int J Cancer Res Ther, 2018
Opdenaker LM, Kowash R, Masters G, Boman BM, Zhang T, Modarai SR.   +5 more
europepmc   +1 more source

Jejunum and ileum histopathology in male Sprague-Dawley rats exposed to alcohol and combination anti-retroviral therapy. [PDF]

Anat Cell Biol
Maseko Z, Johnson JA, Mazengenya P, Luvhengo T, Mbajiorgu EF.   +4 more
europepmc   +1 more source

Expression of stem cell marker musashi-1 and its relationship with survival prognosis in patients with resectable esophageal squamous cell carcinoma. [PDF]

World J Stem Cells
Niu YX, Hu M, Zhao WF, Yang HJ.
europepmc   +1 more source

A Case of Adrenocorticotropin-dependent Cushing Syndrome with Osilodrostat Exposure in Early Pregnancy. [PDF]

JCEM Case Rep
Nakayama Y, Ishikawa M, Watanabe A, Shima Y, Tahara S, Iwabu M.   +5 more
europepmc   +1 more source

Complete Modular Disconnection between AFX2 and VELA Leading to a Type IIIa Endoleak Two Years after Endovascular Aneurysm Repair. [PDF]

Ann Vasc Dis
Mukasa K, Yakita Y, Marushima R, Tsuda M, Abe S, Asano S.   +5 more
europepmc   +1 more source

MSI2 exerts antitumor effects by regulating T-cell function in kidney renal clear cell carcinoma. [PDF]

Transl Androl Urol
Yang S, Zhang X, Chen X, Zheng Q, Wei Q, Yang Y.   +5 more
europepmc   +1 more source

RNA binding protein Musashi1 interacts with the viral genomic RNA and restricts SARS-CoV-2 infection by repressing translation. [PDF]

Nucleic Acids Res
Ganguli S, Gupta D, Kadumuri RV, Tandel D, Ramaswamy R, Krishnan AG, David DT, Bunk S, Chavali S, Harshan KH, Chavali PL.   +10 more
europepmc   +1 more source

Impact of Body Mass Index on Functional Recovery After Total Hip Arthroplasty: A Prospective Study. [PDF]

Arthroplast Today
Ima M, Kabata T, Inoue D, Yanagi Y, Iyobe T, Fujimaru N, Demura S.   +6 more
europepmc   +1 more source

AI in clinical trials: Current status, challenges, and future directions for emergency infectious disease clinical trials -Insights from the 2025 iCROWN Symposium. [PDF]

Glob Health Med
Morino E, Tokita D.
europepmc   +1 more source

Musashi-2 (MSI2) regulation of DNA damage response in lung cancer [PDF]

, 2023
AbstractLung cancer is one of the most common types of cancers worldwide. Non-small cell lung cancer (NSCLC), typically caused byKRASandTP53driver mutations, represents the majority of all new lung cancer diagnoses. Overexpression of the RNA-binding protein (RBP) Musashi-2 (MSI2) has been associated with NSCLC progression.
Igor Bychkov, Alexander Deneka, Iuliia Topchu, Rajendra P. Pangeni, Christopher Lengner, John Karanicolas, Erica A. Golemis, Petr Makhov, Yanis Boumber   +8 more
core   +5 more sources